Response to Cook and Alsina's Letter to Editor

被引：0
作者：
Augsburger, James J. [1 ,4 ]
Skinner, Cassandra C. [2 ]
Correa, Zelia [3 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH USA
[2] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH USA
[3] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL USA
[4] Univ Cincinnati, Coll Med, Dept Ophthalmol, 231 Alert Sabin Way,ML 0527, Cincinnati, OH 45267 USA
来源：
OCULAR ONCOLOGY AND PATHOLOGY | 2023年 / 9卷 / 1-2期
关键词：
D O I：
10.1159/000529562
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：68 / 70
页数：3
相关论文
共 5 条
  • [1] Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas
    Augsburger, James J.
    Correa, Zelia M.
    Trichopoulos, Nikolaos
    Shaikh, Adeel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (07) : 2823 - 2828
  • [2] Frequency and Implications of Discordant Gene Expression Profile Class in Posterior Uveal Melanomas Sampled by Fine Needle Aspiration Biopsy
    Augsburger, James J.
    Correa, Zelia M.
    Augsburger, Bret D.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (02) : 248 - 256
  • [3] Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients
    Ballhausen, Alexej
    Urias, Elizabeth
    Gruschkus, Stephen K.
    Williams, Michelle
    Glover, Maura S.
    Qin, Yong
    Gombos, Dan S.
    Patel, Sapna P.
    [J]. CANCERS, 2021, 13 (13)
  • [4] Do Largest Basal Tumor Diameter and the American Joint Committee on Cancer's Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma
    Demirci, Hakan
    Niziol, Leslie M.
    Ozkurt, Zeynep
    Slimani, Naziha
    Ozgonul, Cem
    Liu, Tiffany
    Musch, David C.
    Materin, Miguel
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 195 : 83 - 92
  • [5] Comparative Metastatic Rates in GEP Class 1A versus 1B Posterior Uveal Melanoma. Results Contrary to Expectations.
    Su, Yixuan J.
    Zhu, Xi C.
    Yuan, Jinlong M.
    Teo, Kok Lay
    Li, Meixia
    Li, Chunfa
    [J]. OCULAR ONCOLOGY AND PATHOLOGY, 2023, 8 (4-6) : 242 - 249
1